# Understanding Patient Preference on Colorectal Cancer Screening Options

> **NCT05536713** · — · COMPLETED · sponsor: **Milton S. Hershey Medical Center** · enrollment: 297 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DEVICE:** Guardant SHIELD blood-based colorectal cancer screening test

## Key facts

- **NCT ID:** NCT05536713
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-09
- **Primary completion:** 2025-12-18
- **Final completion:** 2025-12-18
- **Target enrollment:** 297 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05536713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05536713, "Understanding Patient Preference on Colorectal Cancer Screening Options". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05536713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*